Analyst Consensus ?
ConsensusBuy51 ratings
Bullish3160.8%
Neutral2039.2%
Bearish00.0%
FN2 Earnings Intelligence
Medtronic plc analyst ratings
Medtronic plc (MDT) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$94.79Previous close
$77Low
$104.87Average
$155High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| BTIG | Buy | Buy | Maintain | Oct 12, 2026 |
| TD Cowen | Buy | Buy | Maintain | Sep 30, 2026 |
| UBS | Buy | Buy | Maintain | Sep 3, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Sep 2, 2026 |
| Truist Securities | Hold | Hold | Maintain | Sep 2, 2026 |
| Stifel | Hold | Hold | Maintain | Sep 2, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Sep 2, 2026 |
| Baird | Neutral | Neutral | Maintain | Sep 2, 2026 |
| B of A Securities | Buy | Buy | Maintain | Sep 2, 2026 |
| Needham | Buy | Buy | Maintain | Sep 1, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 6, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jun 5, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jun 5, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Jun 4, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jun 3, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 7, 2026 |
| Argus Research | Buy | Buy | Maintain | Apr 6, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Apr 1, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 1, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Feb 18, 2026 |
| William Blair | Outperform | Market Perform | Upgrade | Jan 6, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Nov 19, 2025 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Jun 30, 2025 |
| Oppenheimer | Perform | Perform | Maintain | Aug 21, 2024 |
| Jefferies | Hold | Hold | Maintain | Oct 12, 2022 |
| Raymond James | Market Perform | Outperform | Downgrade | Aug 24, 2022 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Jun 1, 2022 |
| Deutsche Bank | Buy | Buy | Maintain | May 27, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | May 27, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 23, 2022 |
| SVB Leerink | Market Perform | Market Perform | Maintain | Jan 21, 2022 |
| CFRA | Strong Buy | Buy | Upgrade | May 21, 2020 |
| DZ Bank | Hold | Buy | Downgrade | May 14, 2020 |
| BTIG Research | Buy | Buy | Maintain | Feb 19, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jan 8, 2020 |
| Guggenheim Securities | Buy | Neutral | Upgrade | Jan 2, 2020 |
| Guggenheim | Buy | Neutral | Upgrade | Jan 2, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Aug 21, 2019 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 21, 2019 |
| Argus | Buy | Buy | Maintain | Oct 8, 2018 |
| Bank of America | Buy | Buy | Maintain | Aug 22, 2018 |
| Leerink Swann | Market Perform | Market Perform | Maintain | Oct 9, 2017 |
| Nomura | Buy | Buy | Maintain | Mar 17, 2016 |
| Wedbush | Neutral | Neutral | Maintain | Nov 19, 2014 |
| Sterne Agee | Neutral | Neutral | Maintain | Sep 11, 2014 |
| PiperJaffray | Overweight | Overweight | Maintain | Nov 20, 2013 |
| Wunderlich Securities | Hold | Hold | Maintain | May 22, 2013 |
| Wunderlich | Hold | Hold | Maintain | May 22, 2013 |
| Lazard | Neutral | Buy | Downgrade | Feb 14, 2013 |
| Bank oferica | Buy | Buy | Maintain | Apr 5, 2012 |
| Brean Capital | Buy | Buy | Maintain | Feb 22, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $94.79. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BTIG | Analyst unavailable | $99 | $92.46 | +4.4% | Oct 12, 2026 |
| Barclays | Analyst unavailable | $95 | $87.09 | +0.2% | Oct 6, 2026 |
| Deutsche Bank | Analyst unavailable | $92 | $91.5 | -2.9% | Sep 3, 2026 |
| UBS | Analyst unavailable | $110 | $92.18 | +16.0% | Sep 3, 2026 |
| Mizuho Securities | Anthony Petrone | $115 | $92.18 | +21.3% | Sep 2, 2026 |
| Stifel Nicolaus | Rick Wise | $95 | $92.04 | +0.2% | Sep 2, 2026 |
| Wells Fargo | Larry Biegelsen | $104 | $92.04 | +9.7% | Sep 2, 2026 |
| Truist Financial | Richard Newitter | $99 | $92.04 | +4.4% | Sep 2, 2026 |
| BTIG | Analyst unavailable | $100 | $92.44 | +5.5% | Sep 1, 2026 |
| Needham | Analyst unavailable | $114 | $92.02 | +20.3% | Aug 27, 2026 |
| UBS | Priya Sachdeva | $100 | $84.22 | +5.5% | Jul 28, 2026 |
| BTIG | Ryan Zimmerman | $91 | $83.87 | -4.0% | Jul 13, 2026 |
| Evercore ISI | Analyst unavailable | $105 | $81.61 | +10.8% | Jul 6, 2026 |
| Piper Sandler | Matt O'Brien | $85 | $81.14 | -10.3% | Jun 16, 2026 |
| Goldman Sachs | David Roman | $83 | $82.28 | -12.4% | Jun 5, 2026 |
| Truist Financial | Analyst unavailable | $86 | $81.64 | -9.3% | Jun 4, 2026 |
| Bernstein | Lee Hambright | $97 | $82.54 | +2.3% | Jun 4, 2026 |
| Robert W. Baird | David Rescott | $85 | $77.95 | -10.3% | Jun 4, 2026 |
| UBS | Priya Sachdeva | $85 | $77.95 | -10.3% | Jun 4, 2026 |
| Jefferies | Matthew Taylor | $88 | $77.95 | -7.2% | Jun 4, 2026 |
| BTIG | Analyst unavailable | $90 | $77.95 | -5.1% | Jun 3, 2026 |
| Stifel Nicolaus | Rick Wise | $80 | $77.95 | -15.6% | Jun 3, 2026 |
| Needham | Mike Matson | $101 | $78.03 | +6.6% | Jun 3, 2026 |
| Mizuho Securities | Anthony Petrone | $100 | $73.75 | +5.5% | Jun 3, 2026 |
| Goldman Sachs | Analyst unavailable | $84 | $78.15 | -11.4% | May 21, 2026 |
| Jefferies | Matthew Taylor | $95 | $83.79 | +0.2% | Apr 23, 2026 |
| Truist Financial | Richard Newitter | $95 | $86.88 | +0.2% | Apr 15, 2026 |
| Mizuho Securities | Analyst unavailable | $120 | $86.75 | +26.6% | Apr 13, 2026 |
| Evercore ISI | Vijay Kumar | $106 | $87.91 | +11.8% | Apr 9, 2026 |
| Leerink Partners | Mike Kratky | $119 | $90.3 | +25.5% | Mar 10, 2026 |
| Needham | Michael Matson | $120 | $90.21 | +26.6% | Mar 10, 2026 |
| Robert W. Baird | Analyst unavailable | $100 | $96.41 | +5.5% | Feb 18, 2026 |
| Barclays | Matt Miksic | $118 | $96.41 | +24.5% | Feb 18, 2026 |
| Needham | Analyst unavailable | $121 | $102.9 | +27.7% | Feb 9, 2026 |
| UBS | Analyst unavailable | $104 | $103.38 | +9.7% | Feb 4, 2026 |
| Wells Fargo | Larry Biegelsen | $114 | $101.78 | +20.3% | Jan 30, 2026 |
| Bernstein | Analyst unavailable | $112 | $98.69 | +18.2% | Jan 9, 2026 |
| Barclays | Matt Miksic | $116 | $99.77 | +22.4% | Jan 8, 2026 |
| Truist Financial | Richard Newitter | $107 | $99.14 | +12.9% | Dec 18, 2025 |
| Robert W. Baird | Analyst unavailable | $103 | $98.66 | +8.7% | Dec 16, 2025 |
| Barclays | Analyst unavailable | $111 | $100.34 | +17.1% | Nov 20, 2025 |
| Bernstein | Lee Hambright | $111 | $100.34 | +17.1% | Nov 19, 2025 |
| Leerink Partners | Mike Kratky | $120 | $100.8 | +26.6% | Nov 19, 2025 |
| Jefferies | Matthew Taylor | $110 | $100.8 | +16.0% | Nov 19, 2025 |
| Goldman Sachs | David Roman | $111 | $100.8 | +17.1% | Nov 19, 2025 |
| Bernstein | Lee Hambright | $98 | $91.16 | +3.4% | Oct 31, 2025 |
| Truist Financial | Analyst unavailable | $103 | $95.26 | +8.7% | Oct 15, 2025 |
| RBC Capital | Analyst unavailable | $111 | $95.72 | +17.1% | Oct 10, 2025 |
| Argus Research | David Toung | $115 | $92.18 | +21.3% | Aug 26, 2025 |
| Bernstein | Lee Hambright | $93 | $82.68 | -1.9% | Jan 8, 2025 |
| Robert W. Baird | David Rescott | $96 | $90.01 | +1.3% | Oct 15, 2024 |
| RBC Capital | Shagun Singh | $105 | $88.35 | +10.8% | Oct 10, 2024 |
| Evercore ISI | Vijay Kumar | $104 | $90.03 | +9.7% | Oct 1, 2024 |
| Citigroup | Joanne Wuensch | $92 | $90.03 | -2.9% | Oct 1, 2024 |
| Goldman Sachs | David Roman | $82 | $86.4 | -13.5% | Aug 21, 2024 |
| Oppenheimer | Steven Lichtman | $94 | $86.46 | -0.8% | Aug 21, 2024 |
| Piper Sandler | Matt O'Brien | $90 | $85.38 | -5.1% | Aug 21, 2024 |
| Mizuho Securities | Anthony Petrone | $98 | $86.38 | +3.4% | Aug 21, 2024 |
| Wells Fargo | Larry Biegelsen | $106 | $85.38 | +11.8% | Aug 21, 2024 |
| Stifel Nicolaus | Rick Wise | $87 | $85.38 | -8.2% | Aug 20, 2024 |
| Robert W. Baird | David Rescott | $87 | $81.91 | -8.2% | May 24, 2024 |
| RBC Capital | Shagun Singh | $92 | $81.38 | -2.9% | May 24, 2024 |
| Truist Financial | Richard Newitter | $88 | $81.38 | -7.2% | May 24, 2024 |
| Wells Fargo | Larry Biegelsen | $105 | $81.38 | +10.8% | May 24, 2024 |
| Stifel Nicolaus | Rick Wise | $100 | $81.38 | +5.5% | May 23, 2024 |
| Wells Fargo | Larry Biegelsen | $102 | $80.98 | +7.6% | Sep 13, 2023 |
| Robert W. Baird | David Rescott | $90 | $82.94 | -5.1% | Aug 10, 2023 |
| Wells Fargo | Larry Biegelsen | $100 | $87.29 | +5.5% | Jul 12, 2023 |
| RBC Capital | Analyst unavailable | $89 | $80.86 | -6.1% | Jan 9, 2023 |
| Wells Fargo | Analyst unavailable | $77 | $76.49 | -18.8% | Nov 30, 2022 |
| Barclays | Analyst unavailable | $85 | $79.12 | -10.3% | Nov 25, 2022 |
| Morgan Stanley | Cecilia Furlong | $88 | $78.53 | -7.2% | Nov 23, 2022 |
| Deutsche Bank | Pito Chickering | $80 | $78.53 | -15.6% | Nov 23, 2022 |
| RBC Capital | Analyst unavailable | $102 | $78.84 | +7.6% | Nov 23, 2022 |
| Oppenheimer | Analyst unavailable | $85 | $77.97 | -10.3% | Nov 23, 2022 |
| Citigroup | Analyst unavailable | $85 | $77.93 | -10.3% | Nov 23, 2022 |
| Deutsche Bank | Pito Chickering | $85 | $83.4 | -10.3% | Nov 16, 2022 |
| RBC Capital | Analyst unavailable | $110 | $86.04 | +16.0% | Sep 7, 2022 |
| Morgan Stanley | Analyst unavailable | $101 | $89.32 | +6.6% | Aug 24, 2022 |
| Wells Fargo | Larry Biegelsen | $96 | $90.22 | +1.3% | Aug 24, 2022 |
| Truist Financial | Analyst unavailable | $97 | $88.9 | +2.3% | Jul 20, 2022 |
| Stifel Nicolaus | Analyst unavailable | $105 | $88.94 | +10.8% | Jul 18, 2022 |
| Morgan Stanley | Analyst unavailable | $103 | $89.04 | +8.7% | Jul 15, 2022 |
| Morgan Stanley | Analyst unavailable | $114 | $95.84 | +20.3% | Jun 7, 2022 |
| Truist Financial | Analyst unavailable | $111 | $100.03 | +17.1% | May 31, 2022 |
| Raymond James | Analyst unavailable | $109 | $99.08 | +15.0% | May 31, 2022 |
| Cowen & Co. | Analyst unavailable | $117 | $97.37 | +23.4% | May 27, 2022 |
| RBC Capital | Analyst unavailable | $122 | $98.27 | +28.7% | May 27, 2022 |
| Deutsche Bank | Analyst unavailable | $121 | $98.25 | +27.7% | May 27, 2022 |
| Morgan Stanley | Analyst unavailable | $115 | $98.24 | +21.3% | May 27, 2022 |
| Citigroup | Analyst unavailable | $117 | $98.6 | +23.4% | May 27, 2022 |
| Cowen & Co. | Josh Jennings | $117 | $99.08 | +23.4% | May 27, 2022 |
| RBC Capital | Shagun Singh Chadha | $122 | $99.08 | +28.7% | May 27, 2022 |
| Cowen & Co. | Analyst unavailable | $125 | $104.12 | +31.9% | May 23, 2022 |
| Bank of America Securities | Travis Steed | $135 | $107.65 | +42.4% | Mar 3, 2022 |
| Needham | Michael Matson | $124 | $105.84 | +30.8% | Feb 26, 2022 |
| Raymond James | Jayson Bedford | $116 | $99.98 | +22.4% | Feb 18, 2022 |
| Piper Sandler | Matthew O'Brien | $105 | $102.54 | +10.8% | Feb 16, 2022 |
| Citigroup | Joanne Wuensch | $129 | $107.12 | +36.1% | Jan 19, 2022 |
| Piper Sandler | Matt O’Brien | $110 | $108.55 | +16.0% | Jan 16, 2022 |
| Morgan Stanley | Cecilia Furlong | $120 | $104.54 | +26.6% | Jan 7, 2022 |
| Truist Financial | David Rescott | $124 | $101.05 | +30.8% | Dec 21, 2021 |
| J.P. Morgan | Robbie Marcus | $105 | $99.4 | +10.8% | Dec 17, 2021 |
| Wells Fargo | Larry Biegelsen | $110 | $100.96 | +16.0% | Dec 16, 2021 |
| UBS | Matthew Taylor | $135 | $100.96 | +42.4% | Dec 16, 2021 |
| Guggenheim | Christopher Pasquale | $142 | $113.04 | +49.8% | Nov 24, 2021 |
| Jefferies | Anthony Petrone | $155 | $111.99 | +63.5% | Nov 23, 2021 |
| Argus Research | David Toung | $165 | $131.53 | +74.1% | Aug 27, 2021 |
| Cowen & Co. | Josh Jennings | $141 | $122 | +48.7% | Jun 10, 2021 |
Track every rating change on MDT the moment it posts. Free to start.
Start freeGet the MDT recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.